Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

Summary

VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7J0)...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage